The diagnosis of LCNEC is based on the presence of neuroendocrine morphology and expression of at least one IHC neuroendocrine marker (CD56, synaptophysin (Syn), chromogranin A (CgA)) in at least 10% of tumour cells [1]. The gene discussed is NCAM1; the disease is large cell neuroendocrine carcinoma.